An interventional study of Intramedullary tibial Nail and Intermedullary nail in Tibial Fracture, sponsored by University of Chicago. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-09.
Sponsored by University of Chicago · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 50 studies in Tibial Fractures with a site in United States — 15 open to participants now, 18 under way, 3 of them phase 3. Tibial Fractures · United States.
Among the 50 studies in Tibial Fractures with a site in United States, this one is the 5th largest by planned enrollment of the 38 interventional ones that give a count, is one of 4 that started in 2025, is one of 27 with no phase, reaches primary completion later than 17 of the 17 other live ones, and was the 47th registered.
136 studies on the registry are indexed under Tibial Fractures; 38 are open to participants now.
Browse Tibial Fractures studies →15 of the 50 studies in Tibial Fractures with a site in United States are open now. Recruiting first, the newest first:
Boston Children's Hospital · Sites in United States
Ages 10–21
Brigham and Women's Hospital · Sites in United States
Ages 18+
University of Alabama at Birmingham · Sites in United States
Ages 18–85
Major Extremity Trauma Research Consortium · Sites in United States
Ages 18+
Denver Health and Hospital Authority · Sites in United States
Ages 18–100 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 27 Tibial Fractures studies recruiting now, 13 (48%) set no upper age limit and 7 (26%) stop at 75 or younger; 5 take children under 18; 4 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
50 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 5 · Phase 4 4
First in 2002; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 372 is above the median of 66 across 92 interventional studies indexed under Tibial Fractures.
Median enrollment 53 across the 38 interventional studies, 97 across the 12 observational. Of the 28 that completed or were terminated, 9 (32%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 50 have an industry lead sponsor. The 10 most frequent:
University of Chicago is the lead sponsor of 926 studies on the registry; 187 are open to participants now.
Of its 103 completed or terminated interventional studies of FDA-regulated products, 72 (70%) have results posted.
University of Chicago has 1 study filed under Tibial Fractures — fewer than ten, so there is no comparison to draw.
8 of the studies in Tibial Fractures with a site in United States that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05000281Phase 3Major Extremity Trauma Research ConsortiumEffect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures | 2026-11-30 |
| NCT05766670Phase 3Wake Forest University Health SciencesIntramedullary Calcium Sulfate Antibiotic Depot | 2027-01 |
| NCT05421741Wake Forest University Health SciencesProphylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial | 2026-12 |
| NCT04113044AO Innovation Translation CenterGo Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS® | 2026-12-31 |
| NCT06679049University of Alabama at BirminghamComparison of Healing Measures Tibial Fractures Following Standard Intramedullary Nailing or Micromotion Tibial Intramedullary Nailing | 2027-01-31 |
Add all 8 to your calendar (.ics) → With an account.
Among the 50 studies in Tibial Fractures with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Our null hypothesis is that micromotion tibial intramedullary fixation (IMFN) does not impact union or complication rates when compared to standard of care treatment with non-micromotion tibial nail fixation. There are no current or past randomized controlled trials comparing these fixation techniques to one another. There is good data supporting both the use of intramedullary fixation for tibial fractures alone, and in high-risk patient populations (open fractures, GSW tibial fractures). However, the effectiveness of these methods with respect to each other has never been investigated. The knowledge gained will allow us to potentially influence and adapt protocols to treat this patient population. Additionally, resources available at our institution provide a supportive framework with which to maintain contact with patients after hospital discharge. These key factors will allow us to perform a robust analysis of this population, to include outcomes measures of function and complications.
With much of the limited existing literature on tibial nails being in very defined populations, without a strong comparison group there is no clear guidance on when the use of a micromotion device is indicated. Our approach to randomize our patients will reduce the bias that exists in the current literature and provide a robust spectrum of injuries to sub analyze and compare.
Objectives Primary Objective Compare post-operative union rates in tibial shaft patients treated with 2 types of intramedullary rod fixation devices.
Secondary Objective(s) Compare complication rates, patient reported outcomes, range of motion, pain and radiographic/sonographic outcomes in patients treated with tibial nails.
The advent of the intramedullary nail (IMN) has revolutionized the treatment of tibial shaft fractures due to its percutaneous route of insertion, frequent facilitation of immediate weightbearing, and high rate of union. Recent research has revealed that selection of an appropriate IMN diameter is vital for maintaining fracture reduction and preventing complications. Using a larger diameter nail increases construct stability, permits load-sharing, and may lead to higher rates of union. On the other hand, aggressive reaming to permit a larger nail diameter can result in iatrogenic fracture upon insertion or removal.
Modern tibial nail designs have remained largely unchanged in the last 20 years with small ergonomic and efficiency changes without large scale improvements in their biomechanical induction of bone healing at the fracture site. Traditionally they include distal locking screws as well as proximal locking screws that are either fixed or dynamic allowing for small but largely irrelevant amounts of motion. Our understanding of bone healing and indirect bone generation includes the concept of micromotion which induces the creation of fibrous followed by bony callus. This concept requires strain levels and adequate micromotion at fracture sites to be biomechanically advantageous. One new tibial nail device recently available in the US and FDA approved for tibial nail fixation hopes to improve the biomechanical and biology environment for tibial healing, the OrthoXel tibial nail system. Unfortunately, there is a paucity of strong clinical data to support it. Additionally, there have been no prospective, randomized studies investigating the used of this nail compared to standard tibial nail designs and no studies have evaluated it in high risk tibial non-union patients..
The primary purpose of this study is to perform a high-quality randomized control trial comparing intramedullary tibial nail fixation with standard design nails compared to a micromotion tibial nail device to evaluate the rates of union and post-operative outcomes. In an evaluation of patient factors, fracture patterns and patient reported outcomes, the investigators will bring clarity to the question of indications for the micromotion tibial nail in standard and high risk patients. To characterize our patient population, the investigators will evaluate type of injury (closed, open, gunshot wound), fracture morphology (OTA classification), patient risk factors (age, isolated vs. poly-trauma, Comorbidities, smoking, and Vit D levels) and surgical outcomes (blood loss, surgical time, construct stability). In addition to objective radiographic, ultrasonographic and physical exam outcomes, the investigators will collect patient reported outcomes in the form of PROMIS CAT and VAS scores.
Given the existing limitations in the literature, there is no guidance on indications for use of micromotion tibial nail fixation (MMIMNF) compared to standard intramedullary nail fixation (IMNF). By taking an approach that will be prospective and randomized, while assessing all known risk factors, the investigators expect our results will guide surgical treatment decisions around the use of these devices and in which populations they may be most useful. .
The proposed trial will be a parallel-group, superiority trial with equal randomization enrolling 242 tibial nail patients. Patients will be categorized into 2 cohorts: IMNF fixation(cohort 1), and MicroMotion Intramedullary tibial Nail fixation (cohort 2). The primary outcome will be nonunion. Secondary outcomes will include: overall complications (as a composite result (Infection ((deep and superficial)), revision surgery rate, removal of metalwork, non-union, malunion, amputation and death). Patient-Reported Outcomes Measurement Information System Physical Function Computerized Adaptive Testing (PROMIS PT CAT) scores, range of motion (ROM), pain, radiographic outcomes, time to bridging callus based on mRUST (>11) on Xray, time to single leg stance, and degree of callus seen on ultrasound at 6 \& 12 weeks.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subject will receive micromotion tibial intramedullary fixation
Device: Intramedullary tibial Nail
Subject will receive non-micromotion tibial nail fixation
Device: Intermedullary nail
Subjects will receive the micromotion MicroMotion Intramedullary tibial Nail
Also known as: MicroMotion Intramedullary tibial Nail
The non-micromotion intermedullary nail
Compare post-operative union rates
Compare post-operative union rates in tibial shaft patients treated with 2 types of intramedullary rod fixation devices.
Time frame: six months
Compare complication rates
Compare complication rates outcomes in patients treated with tibial nails
Time frame: one year
Time to single leg stance
Time (in days) it takes for the subject stand on a single leg.
Time frame: one year
Any difference in patient reported outcomes scores physical function
Patient Reported outcome scores physical function scores are reported on a T-score scale that ranges from 20-80, with higher scores indicating greater physical function.
Time frame: one year
Any difference in patient reported outcomes scores pain interference
Patient Reported outcome scores pain interference scores are reported on a T-score scale that ranges from 6-30, with higher scores indicating greater physical function.
Time frame: one year
Ultra sound callus
Checking if a callus has appeared
Time frame: 6 weeks
Ultra sound callus
Checking if callus has appeared
Time frame: 12 weeks
Visual analog pain scale score
Visual analog pain scale scores for the subject. Scored on a scale of 0 - 10. 0 no pain and 10 worst pain.
Time frame: one year
Smoking Status
Comparing the smoking status (yes/no and pack years) and return to OR timelines
Time frame: one year
Visual analog pain scale score
Visual analog pain scale score? 0 (no pain) - 10 (worst pain)
Time frame: one year
Fixation failure rate
Comparing the fixation failure rates between the two groups and return to OR timelines
Time frame: one year
Radiographic Mal-union
Comparing Radiographic Mal-union rates between groups
Time frame: one year
Radiographic Non-union
Comparing rates Radiographic Non-union between groups
Time frame: one year
Any difference in Patient reported outcomes scores depression
Patient Reported outcome scores depression scores are reported on a T-score scale that ranges from 8 - 40, with higher scores indicating greater depression.
Time frame: one year
Reoperation Rate
Comparing Reoperation Rate between groups
Time frame: one year
Any difference in Patient reported outcomes scores anxiety
Patient Reported outcome scores anxiety scores are reported on a T-score scale that ranges from 7 - 35, with higher scores indicating greater anxiety.
Time frame: one year
Infection Rate (Superficial and Deep)
Comparing Infection Rate (Superficial and Deep) between group
Time frame: one year
Amputation Ratee
Comparing Amputation Rate between groups
Time frame: one year
Knee & ankle Range of Motion
Comparing Knee \& ankle Range of Motion between groups
Time frame: one year
Diabetes
Comparing diabetes between subjects and return to OR timelines
Time frame: one year
BMI
Comparing BMI in subjects and and return to OR timelines
Time frame: one year
Plan to share: No — No plan to share individual participant data
Started Jul 2025 (actual). Primary completion is estimated for Dec 2029, 53 months after the start.
Of 39 interventional studies with no phase under Tibial Fractures, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 80. This study's planned 53 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.